Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

Detalles Bibliográficos
Autores principales: Honore, Patrick M., Mugisha, Aude, Barreto Gutierrez, Leonel, Redant, Sebastien, Kaefer, Keitiane, Gallerani, Andrea, De Bels, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907280/
https://www.ncbi.nlm.nih.gov/pubmed/31831032
http://dx.doi.org/10.1186/s13054-019-2692-2
_version_ 1783478520239882240
author Honore, Patrick M.
Mugisha, Aude
Barreto Gutierrez, Leonel
Redant, Sebastien
Kaefer, Keitiane
Gallerani, Andrea
De Bels, David
author_facet Honore, Patrick M.
Mugisha, Aude
Barreto Gutierrez, Leonel
Redant, Sebastien
Kaefer, Keitiane
Gallerani, Andrea
De Bels, David
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-6907280
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69072802019-12-19 Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights Honore, Patrick M. Mugisha, Aude Barreto Gutierrez, Leonel Redant, Sebastien Kaefer, Keitiane Gallerani, Andrea De Bels, David Crit Care Letter BioMed Central 2019-12-12 /pmc/articles/PMC6907280/ /pubmed/31831032 http://dx.doi.org/10.1186/s13054-019-2692-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Honore, Patrick M.
Mugisha, Aude
Barreto Gutierrez, Leonel
Redant, Sebastien
Kaefer, Keitiane
Gallerani, Andrea
De Bels, David
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
title Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
title_full Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
title_fullStr Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
title_full_unstemmed Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
title_short Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
title_sort optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907280/
https://www.ncbi.nlm.nih.gov/pubmed/31831032
http://dx.doi.org/10.1186/s13054-019-2692-2
work_keys_str_mv AT honorepatrickm optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapyadditionalinsights
AT mugishaaude optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapyadditionalinsights
AT barretogutierrezleonel optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapyadditionalinsights
AT redantsebastien optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapyadditionalinsights
AT kaeferkeitiane optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapyadditionalinsights
AT galleraniandrea optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapyadditionalinsights
AT debelsdavid optimizingceftolozanetazobactamdosageduringcontinuousrenalreplacementtherapyadditionalinsights

Ejemplares similares